| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,172 |
15,676 |
$926K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,519 |
5,945 |
$471K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16,544 |
14,792 |
$464K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,858 |
5,498 |
$398K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,333 |
4,834 |
$383K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,873 |
3,829 |
$269K |
| 99215 |
Prolong outpt/office vis |
2,344 |
2,227 |
$226K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,814 |
2,767 |
$214K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13,561 |
13,262 |
$194K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,803 |
18,227 |
$151K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
6,790 |
6,677 |
$136K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,026 |
1,933 |
$70K |
| 92551 |
|
7,380 |
7,102 |
$55K |
| 94664 |
|
5,347 |
4,945 |
$53K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
622 |
573 |
$45K |
| 82962 |
|
17,646 |
15,279 |
$44K |
| 36415 |
Collection of venous blood by venipuncture |
20,814 |
18,244 |
$44K |
| 81001 |
|
12,198 |
11,130 |
$36K |
| 83655 |
|
2,249 |
2,055 |
$24K |
| 99462 |
|
957 |
447 |
$23K |
| 90474 |
|
1,952 |
1,930 |
$17K |
| 82274 |
|
1,091 |
822 |
$17K |
| 99460 |
|
365 |
361 |
$17K |
| 17250 |
|
297 |
223 |
$14K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
245 |
236 |
$13K |
| 82947 |
|
3,105 |
2,919 |
$12K |
| 90620 |
|
393 |
389 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,539 |
5,732 |
$11K |
| 99173 |
|
7,457 |
7,082 |
$9K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
137 |
131 |
$9K |
| 99381 |
|
29 |
29 |
$2K |
| 90686 |
|
6,281 |
6,148 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
174 |
172 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
134 |
132 |
$2K |
| 90715 |
|
524 |
517 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
147 |
135 |
$1K |
| 90651 |
|
729 |
717 |
$796.82 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
5,613 |
5,018 |
$725.59 |
| 90716 |
|
1,340 |
1,297 |
$705.40 |
| 90707 |
|
1,319 |
1,278 |
$316.91 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
228 |
197 |
$227.53 |
| 90734 |
|
470 |
462 |
$133.90 |
| 86308 |
|
13 |
12 |
$61.80 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
124 |
119 |
$40.79 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
133 |
126 |
$0.36 |
| 90680 |
|
1,978 |
1,941 |
$0.00 |
| 90744 |
|
1,384 |
1,363 |
$0.00 |
| 99000 |
|
1,399 |
1,215 |
$0.00 |
| 90619 |
|
34 |
33 |
$0.00 |
| 90677 |
|
121 |
117 |
$0.00 |
| 3008F |
|
151 |
145 |
$0.00 |
| 90685 |
|
1,208 |
1,185 |
$0.00 |
| 90713 |
|
2,912 |
2,852 |
$0.00 |
| 90633 |
|
1,466 |
1,429 |
$0.00 |
| 90700 |
|
3,621 |
3,570 |
$0.00 |
| 90648 |
|
2,954 |
2,899 |
$0.00 |
| 90670 |
|
2,784 |
2,727 |
$0.00 |